Press release, news and achievement template

Headline (this appears on both the home page, news page and in the article page):
New multimillion India-UK research centres
Short headline (70 characters with spaces. Usedfor social media, and on the home page and news page if the original headline is longer than 70 characters. This can be left blank if original headline is less than 70 characters):
Description of preferred image (or specific URL or G drive location – see G:\CAG\Shared\Images):
Summary (270 characters with spaces. This appears on the home page and in search results):
In a landmark collaboration, the Medical Research Council (MRC) and the Government of India Department for Biotechnology (DBT) have joined forces to fund three major global research centres.
Gateway to Research reference:

Paste text below:

In a landmark collaboration, the UK Medical Research Council (MRC) and the Government of India Department for Biotechnology (DBT), have joined forces to fund three major global research centres. Using high quality research teams based in the UK and India, two of the centres will focus on research into antimicrobial resistance (AMR), and the other on cancer biology. Nearly £3.5million will be invested by the UK, through the MRC and the Newton Fund, with matched funding provided by DBT.

The centres will take a global perspective in tackling some of the largest global health problems of today and foster the next generation of researchers with specialist skills.

  • The Cambridge-Chennai Centre Partnership on Antimicrobial Resistant Tuberculosis

A team of international researchers, from across a number of disciplines, will look to develop new diagnostic tools and new treatments to address the sharp rise in cases of multidrug resistant Tuberculosis (MDR-TB). The partnership between the University of Cambridge and the National Institute for Research in Tuberculosis (NIRT) in Chennai, India, will generate a rich and lasting clinical and genomic dataset.

  • UK-India Centre for Advanced Technology for Minimising the indiscriminate use of Antibiotics (UKICAT-MA)

This centre will focus on finding solutions to the excessive and inappropriate use of antibiotics. In partnership with the University of Sheffield, University of Bradford and L V Prasad Eye Institute in India, the new centre will establish smart materials for the detection and targeted delivery of antibiotics for eye infections, and promote the use of these new technologies in other infective diseases.

  • MRC-DBT Joint Centre for Cancer Biology & Therapeutics

Cancer is among the leading causes of disease and death worldwide. The World Health Organization estimates that the number of new cases will rise by about 70% over the next two decades. This centre will link the MRC Cancer Unit at the University of Cambridge with the National Centre for Biological Sciences in India to foster research on cancer biology and therapy in India through collaborative research programmes, translational research and capacity building.

Prof K. VijayRaghavan, Secretary, Department of Biotechnology stated:

“The Department of Biotechnology, Government of India is delighted to partner with the MRC in creating research centres which will address vexing challenges in medicine through quality science and collaboration. India is committed to working with the best in the world, for India and for the world. We are acutely aware that the fruits of our partnership can mean better lives for the most- needy everywhere and are committed to make the collaboration succeed.”

Dr Mark Palmer MRC Director of International Strategy, said:

“With a 100-year history of strategic international collaboration, MRC scientists today collaborate with researchers in more than 100 countries. We know diseases don’t recognise international borders and that addressing health problems around the world demands a global response. These exciting partnerships between excellent scientists in India and the UK is a key part of our international effort to pool expertise and resources and deliver research that will make a real difference to global health.”

The Newton Fund is a new initiative which will enable the UK to use its strength in research and innovation to promote the economic development and social welfare of 15 partner countries. The Fund will help countries that are rapidly improving their own scientific capability and will help to unlock further opportunitiesfor science and innovation collaboration.

News carousel summary (90 characters with spaces and ellipsis. This appears on the news page and is not required for achievements.Can be a new summary, or a truncated version of original summary/first paragraph with ellipsis.)
Type (select one)
[Not required for achievements]
☒ / Press release
☒ / News item
Achievement? (optional)
☐ / Achievement
News category (select one)
[Not required for achievements]
☐ / Research
☒ / Funding
☐ / Corporate
Health category (up to five)
☐ / Blood
☒ / Cancer
☐ / Cardiovascular
☐ / Congenital
☐ / Ear
☐ / Eye
☒ / Infection
☐ / Inflammatory
☐ / Injuries
☐ / Mental Health
☐ / Metabolic
☐ / Musculoskeletal
☐ / Neurological
☐ / Oral & Gastro
☐ / Renal
☐ / Reproduction
☐ / Respiratory
☐ / Skin
☐ / Stroke
☐ / Generic
☐ / Other
Strategic plan objective
(no maximum, use aim only if no specific objective is appropriate)
☐ / Natural protection
☐ / Tissue disease and degeneration
☐ / Mental health and wellbeing
☐ / Repair and replacement
☐ / Molecular datasets and disease
☐ / Life course perspective
☐ / Lifestyles affecting health
☐ / Environment and health
☐ / Securing impact from medical research
☐ / Regulation, ethics, governance and working with decision-makers
☐ / Engagement
☒ / International partnerships and shaping the agenda
☒ / Global health
☐ / Capacity and skills
☐ / Research environment
☒ / Aim: Picking research that delivers
☒ / Aim: Research to people
☒ / Aim: Going global
☒ / Aim: Supporting scientists
Location (no maximum)
☐ / Aberdeen
☐ / Belfast
☐ / Birmingham
☐ / Brighton
☐ / Bristol
☒ / Cambridge
☐ / Cardiff
☐ / Dundee
☐ / Edinburgh
☐ / Glasgow
☐ / Harwell
☐ / Leicester
☐ / Liverpool
☐ / London
☐ / Manchester
☐ / Newcastle
☐ / Nottingham
☐ / Oxford
☒ / Sheffield
☐ / Southampton
☐ / The Gambia
☐ / Uganda
☒ / Other

Home page placement [not required for achievements]:
(By default we will move stories through the home page in the order of top > sub left > sub right as new press releases and web stories are published. Please check this box if you would like the news story to be put directly into a sub sloteg if you don’t want the current top story moving down.)

☐Straight into sub story slot

Tips on health categories coding

If you have a Gateway to Research reference (‘G’ number), you can get the health categories coding from there. In the absence of a G number, please use the following guidance to apply health categories to the content.

General points

  • Most categories include normal/healthy processes as well as disease.
  • It’s fine to use more than one health category eg post-natal depression: mental health, and reproductive health and childbirth.

Categories

Blood

Haematological diseases, anaemia, clotting and normal development and function of platelets and erythrocytes.

Cancer

All types of cancers (includes leukaemia). Cancers should not be tagged to the body location eg lung cancer is not respiratory.

Cardiovascular

Coronary heart disease, diseases of the vasculature and circulation including the lymphatic system, and normal development and function of the cardiovascular system.

Congenital disorders

Physical abnormalities and syndromes that are not associated with a single type of disease or condition, including Down's syndrome and cystic fibrosis. Use for physical abnormalities/congenital syndromes that are associated with multiple conditions, not for all inherited disorderseg congenital heart defects should be coded cardiovascular.

Ear

Deafness and normal ear development and function.

Eye

Diseases of the eye and normal eye development and function.

Infection

Diseases caused by pathogens, acquired immune deficiency syndrome, sexually transmitted infections, and studies of infection and infectious agents. Not vCJD (neurological). Do not code by site eg respiratory tract infections are infection, not respiratory

Inflammatory and immune system

Rheumatoid arthritis, connective tissue diseases, autoimmune diseases, allergies, and normal development and function of the immune system.Not asthma (respiratory).

Injuries and accidents

Fractures, poisoning and burns.

Mental health

Depression, schizophrenia, psychosis and personality disorders, addiction, suicide, anxiety, eating disorders, learning disabilities, autistic spectrum disorders, and studies of normal psychology, cognitive function and behaviour.Not dementias (neurological).

Metabolic and endocrine

Diabetes, thyroid disease, metabolic disorders, and normal metabolism and endocrine development and function.

Musculoskeletal

Osteoporosis, osteoarthritis, muscular and skeletal disorders and normal musculoskeletal and cartilage development and function.

Neurological

Dementias, transmissible spongiform encephalopathies, Parkinson's disease, neurodegenerative diseases, Alzheimer's disease, epilepsy, multiple sclerosis and studies of the normal brain and nervous system.

Oral and gastrointestinal

Inflammatory bowel disease, Crohn's disease, diseases of the mouth, teeth, oesophagus, digestive system including liver and colon, and normal oral and gastrointestinal development and function.

Renal and urogenital

Kidney disease, pelvic inflammatory disease, renal and genital disorders, and normal development and function of male and female renal and urogenital system.

Reproductive health and childbirth

Fertility, contraception, abortion,in vitrofertilisation, pregnancy, mammary gland development, menstruation and menopause, breast feeding, antenatal care, childbirth and complications of newborns.

Respiratory

Asthma, chronic obstructive pulmonary disease, respiratory diseases and normal development and function of the respiratory system.Not respiratory tract infections (infection).

Skin

Dermatological conditions, and normal skin development and function.

Stroke

Ischaemic and haemorrhagic.

Generic health relevance

Research applicable to all diseases and conditions or to general health and well-being of individuals. Public health research, epidemiology and health services research that is not focused on specific conditions. Underpinning/fundamental/basic biological, psychosocial, economic or methodological studies that are not specific to individual diseases or conditions.

Other

Conditions of unknown or disputed cause (such as chronic fatigue syndrome/myalgic encephalomyelitis), or research that is not of generic health relevance and not applicable to specific health categories listed above. Should be used infrequently – this is not a dumping ground.

Topics spanning multiple categories

Always tag these topics with these sets of categories:

Tobacco/smoking / Diet/obesity / Physical activity / Alcohol
Cancer / Cancer / Cancer / Cancer
Cardiovascular / Cardiovascular / Cardiovascular / Cardiovascular
Respiratory / Metabolic & endocrine / Metabolic & endocrine / Oral & gastrointestinal
Stroke / Oral & gastrointestinal / Oral & gastrointestinal / Stroke
Stroke